Epigral Limited has submitted a regulatory disclosure to the National Stock Exchange of India Limited and BSE Limited regarding an upcoming plant visit for investors and analysts.
The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Event Details:
- Organizer: Elara Securities (India) Pvt. Ltd.
- Date: Thursday, 22nd October, 2026
- Mode: Physical Plant Visit
- Location: Dahej, Gujarat
The company notes that the schedule is subject to change due to exigencies on the part of the analyst, investor, or the company itself.
A critical disclaimer states that no unpublished price sensitive information (UPSI) will be shared or discussed during the plant visit with the investors or analysts.
The letter was digitally signed by Gaurang Ghanshyam Trivedi, Company Secretary and Compliance Officer (Membership No. A22307), on behalf of Epigral Limited on October 21, 2026, at 09:48 IST.